CHEManager International: Defining New Rules – The Evolution of the CDMO Industry

CHEManager International’s recent issue features an article from Gavin Murdoch, VP Commercial Strategy at Abzena. Gavin’s article took a look at the evolution of the CDMO sector as it is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

CHEManager asked executives and industry experts from a broad range of CDMOs to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges. We proposed to discuss the following aspects:

• (How) have the rules of the CDMO market changed since the pandemic of 2020/21?
• What do you consider the most important growth drivers for CDMOs?
• What is your company’s strategy to grow the market share in the CDMO industry?

Gavins article featured his thoughts on a secure and resilient supply chain which is crucial. To read more, please click the link below.

Click here to access the full article